Diarrhoea in a Melanoma Patient

Abstract

Case report of a female with malignant melanoma, developing diarrhoea following administration of Pembrolizumab. Macroscopic investigation was normal, but histology was in keeping with lymphocytic colitis secondary to drug related injury, which is the first to be described with this immunotherapy.